Tien Liang BioTech Co., Ltd. (TPEX:4127)

Tien Liang BioTech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	147.19	130.67	142.22	107.84	118.47	115.24
Cash & Short-Term Investments	177.19	130.67	142.22	107.84	118.47	115.24
Cash Growth	3.87%	-8.12%	31.87%	-8.97%	2.81%	32.00%
Accounts Receivable	36.09	40.89	75.04	97.05	97.84	67.09
Other Receivables	0.1	0.1	0.01	0.01	-	0
Receivables	36.19	40.98	75.05	97.07	97.84	67.1
Inventory	60.46	58.49	75.8	94.97	60.95	52.58
Prepaid Expenses	37.42	8.82	11.15	22.48	13.4	12.52
Other Current Assets	8.1	7.58	4.83	3.92	4.22	4.16
Total Current Assets	319.35	246.54	309.04	326.27	294.89	251.6
Property, Plant & Equipment	323.24	324.07	334.03	339.2	349.48	360.16
Long-Term Investments	401.08	296.65	-	-	-	-
Other Intangible Assets	0.4	0.44	0.51	0.24	0.62	1.21
Long-Term Deferred Tax Assets	4.99	5.36	5.6	5.89	5.79	7.96
Other Long-Term Assets	15.54	15.62	4.86	4.82	4.58	4
Total Assets	1,065	888.68	654.04	676.43	655.35	624.94
Accounts Payable	68.99	32.9	25.9	26.05	46.41	26.8
Accrued Expenses	21.46	28.33	29.55	40.46	28.61	21.11
Short-Term Debt	455	335	70	100	130.5	170.5
Current Portion of Leases	0.25	0.38	0.5	0.52	0.78	0.76
Current Income Taxes Payable	-	-	0.73	-	-	-
Current Unearned Revenue	-	-	-	-	-	2.89
Other Current Liabilities	18.66	10.78	18.17	18.49	17.86	18.85
Total Current Liabilities	564.37	407.38	144.85	185.51	224.16	240.9
Long-Term Leases	-	-	0.38	0.88	1.4	2.17
Long-Term Deferred Tax Liabilities	2.17	3.38	0.03	0.4	0.05	-
Total Liabilities	566.54	410.76	161.05	201.3	241.3	257.68
Common Stock	457.6	457.6	457.6	457.6	457.6	457.6
Retained Earnings	50.55	32.93	35.38	17.53	-43.55	-90.35
Comprehensive Income & Other	-10.1	-12.6	-	-	-	-
Shareholders' Equity	498.06	477.92	492.98	475.13	414.05	367.25
Total Liabilities & Equity	1,065	888.68	654.04	676.43	655.35	624.94
Total Debt	455.25	335.38	70.88	101.4	132.67	173.43
Net Cash (Debt)	-278.07	-204.71	71.34	6.44	-14.21	-58.2
Net Cash Growth	-	-	1007.04%	-	-	-
Net Cash Per Share	-6.08	-4.47	1.56	0.14	-0.31	-1.27
Filing Date Shares Outstanding	45.76	45.76	45.76	45.76	45.76	45.76
Total Common Shares Outstanding	45.76	45.76	45.76	45.76	45.76	45.76
Working Capital	-245.02	-160.84	164.19	140.76	70.73	10.7
Book Value Per Share	10.88	10.44	10.77	10.38	9.05	8.03
Tangible Book Value	497.66	477.48	492.47	474.88	413.43	366.04
Tangible Book Value Per Share	10.88	10.43	10.76	10.38	9.03	8.00
Land	144.74	144.74	144.74	144.74	144.74	144.74
Buildings	298.44	298.32	298.05	297.83	297.83	297.59
Machinery	89.08	87.73	103.86	99.44	99.39	101.48
Leasehold Improvements	-	-	-	-	0.27	0.27

Source: S&P Global Market Intelligence. Standard template. Financial Sources.